The Journal of Neuroscience, September 6, 2006, 26(36):9227-9238; doi:10.1523/JNEUROSCI.0341-06.2006
Previous Article | Next Article 
Cellular/Molecular
The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease
Shigeki Arawaka,1 *
Manabu Wada,1
Saori Goto,1
Hiroki Karube,1
Masahiro Sakamoto,1
Chang-Hong Ren,1
Shingo Koyama,1
Hikaru Nagasawa,1
Hideki Kimura,1
Toru Kawanami,1
Keiji Kurita,1
Katsushi Tajima,1
Makoto Daimon,1
Masanori Baba,8
Takashi Kido,8
Sachiko Saino,2
Kaoru Goto,2
Hironobu Asao,3
Chihumi Kitanaka,4
Emi Takashita,5
Seiji Hongo,5
Takao Nakamura,6
Takamasa Kayama,7
Yoshihiro Suzuki,9
Kazuo Kobayashi,10
Tadashi Katagiri,11
Katsuro Kurokawa,12
Masayuki Kurimura,13
Itaru Toyoshima,14
Kazuhiro Niizato,15
Kuniaki Tsuchiya,16
Takeshi Iwatsubo,17
Masaaki Muramatsu,8
Hiroto Matsumine,8 and
Takeo Kato1 *
Departments of 1Neurology, Hematology, Metabolism, Endocrinology and Diabetology, 2Anatomy and Cell Biology, 3Immunology, 4Molecular Cancer Science, 5Infectious Diseases, 6Biomedical Information Engineering, and 7Neurosurgery, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan, 8Hubit Genomics, Tokyo 102-0092, Japan, 9Department of Neurology, Yamagata Prefectural Nihonkai Hospital, Yamagata 998-0828, Japan, 10Department of Neurology, Yamagata City Saiseikan Hospital, Yamagata 990-8533, Japan, 11Department of Neurology, Yamagata Prefectural Kahoku Hospital, Yamagata 999-3511, Japan, 12Department of Neurology, Yamagata Prefectural Shinjo Hospital, Yamagata 996-0025, Japan, 13Department of Neurology, Yonezawa City Hospital, Yamagata 992-8502, Japan, 14First Department of Internal Medicine, Akita University School of Medicine, Akita 010-8543, Japan, Departments of 15Psychiatry and 16Laboratory Medicine and Pathology, Tokyo Metropolitan Matsuzawa Hospital, Tokyo 156-0057, Japan, and 17Department of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Science, University of Tokyo, Tokyo 113-0033, Japan
Correspondence should be addressed to Takeo Kato, Department of Neurology, Hematology, Metabolism, Endocrinology, and Diabetology, Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan. Email: tkato{at}med.id.yamagata-u.ac.jp
Sporadic Parkinson's disease (sPD) is a common neurodegenerative disorder, characterized by selective degeneration of dopaminergic neurons in the substantia nigra. Although the pathogenesis of the disease remains undetermined, phosphorylation of
-synuclein and its oligomer formation seem to play a key role. However, the protein kinase(s) involved in the phosphorylation in the pathogenesis of sPD has not been identified. Here, we found that G-protein-coupled receptor kinase 5 (GRK5) accumulated in Lewy bodies and colocalized with
-synuclein in the pathological structures of the brains of sPD patients. In cotransfected cells, GRK5 phosphorylated Ser-129 of
-synuclein at the plasma membrane and induced translocation of phosphorylated
-synuclein to the perikaryal area. GRK5-catalyzed phosphorylation also promoted the formation of soluble oligomers and aggregates of
-synuclein. Genetic association study revealed haplotypic association of the GRK5 gene with susceptibility to sPD. The haplotype contained two functional single-nucleotide polymorphisms, m22.1 and m24, in introns of the GRK5 gene, which bound to YY1 (Yin Yang-1) and CREB-1 (cAMP response element-binding protein 1), respectively, and increased transcriptional activity of the reporter gene. The results suggest that phosphorylation of
-synuclein by GRK5 plays a crucial role in the pathogenesis of sPD.
Key words:
-synuclein; GRK5; haplotype; Lewy body; phosphorylation; SNP
Received Oct. 6, 2005;
revised July 24, 2006;
accepted July 27, 2006.
Correspondence should be addressed to Takeo Kato, Department of Neurology, Hematology, Metabolism, Endocrinology, and Diabetology, Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan. Email: tkato{at}med.id.yamagata-u.ac.jp
This article has been cited by other articles:

|
 |

|
 |
 
O. S. Gorbatyuk, S. Li, L. F. Sullivan, W. Chen, G. Kondrikova, F. P. Manfredsson, R. J. Mandel, and N. Muzyczka
The phosphorylation state of Ser-129 in human {alpha}-synuclein determines neurodegeneration in a rat model of Parkinson disease
PNAS,
January 15, 2008;
105(2):
763 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kaneko, A. Kakita, K. Kasuga, H. Nozaki, A. Ishikawa, A. Miyashita, R. Kuwano, G. Ito, T. Iwatsubo, H. Takahashi, et al.
Enhanced Accumulation of Phosphorylated {alpha}-Synuclein and Elevated -Amyloid 42/40 Ratio Caused by Expression of the Presenilin-1 {Delta}T440 Mutant Associated with Familial Lewy Body Disease and Variant Alzheimer's Disease
J. Neurosci.,
November 28, 2007;
27(48):
13092 - 13097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thomas and M. F. Beal
Parkinson's disease
Hum. Mol. Genet.,
October 15, 2007;
16(R2):
R183 - R194.
[Abstract]
[Full Text]
[PDF]
|
 |
|